2022
DOI: 10.1055/s-0042-1751036
|View full text |Cite
|
Sign up to set email alerts
|

Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

Abstract: Lipid-based nanocarriers have been extensively investigated for drug delivery due to their advantages including biodegradability, biocompatibility, nontoxicity, and nonimmunogenicity. However, the shortcomings of traditional lipid-based nanocarriers such as insufficient targeting, capture by the reticuloendothelial system, and fast elimination limit the efficiency of drug delivery and therapeutic efficacy. Therefore, a series of multifunctional lipid-based nanocarriers have been developed to enhance the accumu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 190 publications
0
3
0
Order By: Relevance
“…Their elegance lies in their ability to overcome some of the most pressing challenges in drug delivery -improving the solubility of poorly water-soluble drugs, protecting labile compounds from degradation, and precisely targeting disease sites within the body. 187,198,199,[203][204][205][206][207][208][209][210][211] A strong advantage of lipid nanoparticles drug carriers is the fact that most of their components are physiological lipids and excipients which are generally recognized as safe (GRAS). 200 They are superior to other nanosized drug delivery systems in minimizing systemic toxicity while maintaining adequate solubility 201 and constitute a common type of regulatory approved nanomedicines.…”
Section: Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…Their elegance lies in their ability to overcome some of the most pressing challenges in drug delivery -improving the solubility of poorly water-soluble drugs, protecting labile compounds from degradation, and precisely targeting disease sites within the body. 187,198,199,[203][204][205][206][207][208][209][210][211] A strong advantage of lipid nanoparticles drug carriers is the fact that most of their components are physiological lipids and excipients which are generally recognized as safe (GRAS). 200 They are superior to other nanosized drug delivery systems in minimizing systemic toxicity while maintaining adequate solubility 201 and constitute a common type of regulatory approved nanomedicines.…”
Section: Nanoparticlesmentioning
confidence: 99%
“…Their elegance lies in their ability to overcome some of the most pressing challenges in drug delivery -improving the solubility of poorly water-soluble drugs, protecting labile compounds from degradation, and precisely targeting disease sites within the body. 187,[203][204][205][206][207][208][209][210][211] Lipid NPs have a wide range of applications, including cancer therapy (reducing systemic toxicity and enabling targeted delivery), infectious disease treatment (improving drug stability and selective delivery to infected tissues), vaccine delivery (enhancing immune responses), and gene therapy (safe and efficient gene transfection). 194,212 They are employed also in the treatment of neurological disorders (overcoming bloodbrain barrier challenges), ophthalmic conditions (enhancing drug retention in the eye), cardiovascular therapies (improving drug solubility and controlled release), and more.…”
Section: Nanoparticlesmentioning
confidence: 99%
“… 6 Lipid-based nanocarriers have gained significant attention as they offer several advantages such as facile preparation, high encapsulation efficiency of water-insoluble drug molecules, excellent biocompatibility, and low cytotoxicity. 7 Furthermore, chemical modification of lipid-based nanocarriers allows precise control of membrane properties and functions, realising specific targeting 8 and stimuli-responsive release of entrapped drug molecules. 9 Due to their potential in molecular therapies, several nanomedicines employing lipid-based nanocarriers have been already approved for clinical usage.…”
Section: Introductionmentioning
confidence: 99%